Dr. Mark Faries attended Cornell University Medical College, did both his internship and residency at the Hospital of the University of Pennsylvania and completed his fellowship at the John Wayne Cancer Institute. Dr. Faries has also served as an associate professor at the Yale School of Medicine.
Dr. Faries specializes in melanoma and cutaneous oncology. He leads several clinical trials, including the Multicenter Selective Lymphadenectomy (II) trial, which includes thousands of patients throughout the world. Results of this trial were recently published in the New England Journal of Medicine. Dr. Faries also is a member of the AJCC Melanoma Staging Committee, the American Society of Clinical Oncology Guidelines Committee for Melanoma and is on the Editorial Board of the Annals of Surgical Oncology.
Dr. Faries has overseen clinical trials that have included over 6,000 patients and has been awarded substantial research funding by the National Cancer Institute. He was the first surgeon in California to perform minimally invasive inguinal lymph node dissections. He established a Food and Drug Administration - certified cellular immunotherapy lab, and has published over 150 manuscripts, abstracts and book chapters. He has given invited lectures in nine countries on three continents.
In addition to his role at The Angeles Clinic and Research Institute, Dr. Faries will serve as the Associate Director of Surgical Oncology Experimental Therapeutics, Cedars Sinai Department of Surgery at the Cedars-Sinai Medical Center.